Karine Chung, MD – Publications

PEER REVIEW:

  1. McKenna DS, Chung K, Iams JD. Effect of digital cervical examination on the expression of fetal fibronectin. J Reprod Med 1999;44:796-800.
  2. Chung K, Irani J, Knee G, Efymow B, Blasco L, Patrizio P. Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania. Eur J Obstet Gynecol Reprod Biol 2004;113(Suppl 1):S7-11.
  3. Barnhart K, Sammel MD, Chung K, Zhou L, Hummel AC, Guo W. Decline of serum human chorionic gonadotropin and spontaneous complete abortion: defining the normal curve. Obstet Gynecol 2004;104:975-81.
  4. Chung K, Krey L, Katz J, Noyes N. Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists. Fertil Steril 2005;84:313-8.
  5. Chung K, Sammel M, Zhou L, Hummel A, Guo W, Barnhart K. Defining the curve when initial levels of human chorionic gonadotropin in patients with spontaneous abortions are low. Fertil Steril 2006;85:508-10.
  6. Chung K, Sammel MD, Coutifaris C, Chalian R, Lin K, Castelbaum AJ, Freedman MF, Barnhart KT. Defining the rise of serum HCG in viable pregnancies achieved through use of IVF. Hum Reprod 2006;21:823-8.
  7. Chung K, Coutifaris C, Chalian R, Lin K, Ratcliffe SJ, Castelbaum AJ, Freedman MF, Barnhart KT. Factors influencing adverse perinatal outcomes in pregnancies achieved through use of in vitro fertilization. Fertil Steril 2006;86:1634-41.
  8. Barnhart KT, Casanova B, Sammel MD, Timbers K, Chung K, Kulp JL. Prediction of location of a symptomatic early gestation based solely on clinical presentation. Obstet Gynecol 2008;112:1319-26.
  9. Pearce CL, Chung K, Pike MC, Wu AH. Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progrestin. Cancer 2009;115:531-9.
  10. Rudick B, Opper N, Paulson R, Bendikson K, Chung K. The status of oocyte cryopreservation in the United States. Fertil Steril 2010;94:2642-6.
  11. Chung K, Fogle R, Bendikson K, Christenson K, Paulson R. Microdose gonadotropin-releasing hormone agonist in the absence of exogenous gonadotropins is not sufficient to induce multiple follicle development. Fertil Steril 2011;95:317-9.
  12. Rausch ME, Sammel MD, Takacs P, Chung K, Shaunik A, Barnhart KT. Development of a multiple marker test for ectopic pregnancy. Obstet Gynecol 2011;117:573-82.
  13. Barnhart K, van Mello NM, Bourne T, Kirk E, Van Calster B, Bottomley C, Chung K, Condous G, Goldstein S, Hajenius PJ, Mol BW, Molinaro T, O’Flynn O’Brien KL, Husicka R, Sammel M, Timmerman D. Pregnancy of unknown location: A consensus statement of nomenclature, definitions, and outcome. Fertil Steril 2011;95:857-66.
  14. Rausch ME, Beer L, Sammel MD, Takacs P, Chung K, Shaunik A, Speicher D, Barnhart KT. A disintegrin and metalloprotease protein-12 as a novel marker for the diagnosis of ectopic pregnancy. Fertil Steril 2011;95:1373-8.
  15. Su HI, Chung K, Sammel MD, Gracia CR, DeMichele A. Antral follicle count provides additive information to hormone measures for determining ovarian function in breast cancer survivors. Fertil Steril 2011;95:1857-9.
  16. Chung K, Chandavarkar U, Opper N, Barnhart K. Reevaluating the role of dilation and curettage in the diagnosis of pregnancy of unknown location. Fertil Steril 2011;96:659-62.
  17. Morse CB, Sammel MD, Shaunik A, Allen-Taylor L, Oberfoell NL, Takacs P, Chung K, Barnhart KT. Performance of human chorionic gonadotropin curves in women at risk for ectopic pregnancy: Exceptions to the rules. Fertil Steril 2012;97:101-6.
  18. Rausch M, Lorch S, Chung K, Frederick M, Zhang J, Barnhart K. A cost-effectiveness analysis of surgical versus medical management of early pregnancy loss. Fertil Steril 2012;97:355-60.
  19. Chung K, Hovanessian-Larsen LJ, Hawes D, Taylor D, Downey S, Spicer DV, Stanczyk FZ, Patel S, Anderson AR, Pike MC, Wu AH, Pearce CL. Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation. Breast Cancer Res Treat 2012;132:653-60.
  20. Dillon KE, Sioulas VD, Sammel MD, Chung K, Takacs P, Shaunik A, Barnhart KT. How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: Differences by race and ethnicity. Fertil Steril 2012;98:911-6.
  21. Rudick B, Ingles S, Chung K, Stanczyk F, Paulson R, Bendikson K. Characterizing the influence of vitamin D levels on IVF outcomes. Hum Reprod 2012;27:3321-7.
  22. Rubal L, Chung K. Do you need to definitively diagnose the location of a pregnancy of unknown location? The case for “yes”. Fertil Steril 2012;98:1078-84.
  23. Barnhart KT, Sammel MD, Takacs P, Chung K, Morse CB, O’Flynn O’Brien K, Allen-Taylor L, Shaunik A. Validation of a clinical risk scoring system, based solely on clinical presentation, for the management of pregnancy of unknown location. Fertil Steril 2013;99:193-8.
  24. Quaas AM, Melamed A, Chung K, Bendikson KA, Paulson RJ. Egg banking in the United States: Current status of commercially available cryopreserved oocytes. Fertil Steril 2013;99:827-31.
  25. Chung K, Donnez J, Ginsburg E, Meirow D. Emergency IVF versus ovarian tissue cryopreservation: Decision making in fertility preservation for female cancer patients. Fertil Steril 2013;99:1534-42.
  26. Butts SF, Guo W, Cary MS, Chung K, Takacs P, Sammel MD, Barnhart KT. Predicting the decline in human chorionic gonadotropin in a resolving pregnancy of unknown location. Obstet Gynecol 2013;122:337-43.
  27. Rudick BJ, Ingles SA, Chung K, Stanczyk FZ, Paulson RJ, Bendikson KA. Influence of vitamin D levels on in vitro fertilization outcomes in donor-recipient cycles. Fertil Steril 2014;101:447-52.
  28. Ross L, Chung K, Macdonald H. Fertility preservation in the female cancer patient. J Surg Oncol 2014;110:907-11.
  29. Dominick SA, Whitcomb BW, Gorman JR, Mersereau JE, Chung K, Su HI. Factors associated with pregnancy attempts among female young adult cancer survivors. J Cancer Surviv 2014;8:571-9.
  30. Zee J, Sammel MD, Chung K, Takacs P, Bourne T, Barnhart KT. Ectopic pregnancy prediction in women with a pregnancy of unknown location: Data beyond 48 h are necessary. Hum Reprod 2014;29:441-7.
  31. Su HC, Haunschild C, Chung K, Komrokian S, Boles S, Sammel MD, DeMichele A. Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients. Cancer 2014;120:3691-8.
  32. Burks HR, Ross L, Opper N, Paulson E, Stanczyk FZ, Chung K. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation? Fertil Steril 2015;104:643-8.
  33. Burks H, Buckbinder J, Francis-Hernandez M, Chung K, Jabara S, Bendikson K, Paulson R. Developmentally delayed cleavage-stage embryos maintain comparable implantation rates in frozen embryo transfers. J Assist Reprod Genet 2015;32:1477-81.
  34. Cameron KE, Senapati S, Sammel MD, Chung K, Takacs P, Molinaro T, Barnhart KT. Following declining human chorionic gonadotropin values in pregnancies of unknown location. When is it safe to stop? Fertil Steril 2016;105:953-7.
  35. Paulson RJ, Chung K, Quaas AM, Mucowski SJ, Jabara SI, Bendikson KA. Low-dose human chorionic gonadotropin alone can complete follicle maturity: Successful application to modified natural cycle in vitro fertilization. Fertil Steril 2016;105:1228-31.
  36. Barnhart KT, Guo W, Cary MS, Morse CB, Chung K, Takacs P, Senapati S, Sammel MD, Differences in serum human chorionic gonadotropin rise in early pregnancy by race and value at presentation. Obstet Gynecol 2016;128:504-11.
  37. Homer MV, Charo LM, Natarajan L, Haunschild C, Chung K, Mao JJ, DeMichele AM, Su HI. Genetic variants of age at menopause are not related to timing of ovarian failure in breast cancer survivors. Menopause, in press.
  38. Rudick B, Friedman L, Opper N, Chung K, Paulson R, Bendikson K. The natural progression of endometrial polyps in an infertile population. Fertil Steril, submitted.

NON-PEER REVIEW:

  1. Chung K, Allen R. The use of serial human chorionic gonadotropin levels to establish a viable or a nonviable pregnancy. In: Barnhart KT, guest editor. Early Pregnancy Disorders: An Update and Eye to the Future. Semin Reprod Med 2008;26:383-90.
  2. Chung K, Paulson RJ. Fertility preserving options for women of advancing age. UpToDate.

CHAPTER IN BOOK:

  1. Chung K, Mastroianni L Jr. Psychosexual effects of menopause. In: Tulandi T, Gelfand MM, editors: Androgens and Reproductive Aging, 2006, pp. 43-55, Taylor & Francis, Abingdon, Oxon, United Kingdom.
  2. Rudick B, Chung K. Primary amenorrhea. In: Management of Common Problems in Obstetrics and Gynecology, 5th Edition. Goodwin TM, Montoro MN, Muderspach LI, Paulson RJ, Roy S, editors, 2010, pp. 389-93. Wiley-Blackwell, Oxford, UK.
  3. Chung K, Paulson RJ. Fertility preservation and oocyte cryopreservation. In: Management of Common Problems in Obstetrics and Gynecology, 5th Edition. Goodwin TM, Montoro MN, Muderspach LI, Paulson RJ, Roy S, editors, 2010, pp. 468-71. Wiley-Blackwell, Oxford, UK.

ABSTRACTS:

  1. Noyes N, Chung K, Katz J, Krey L. Is exogenous LH necessary when using GnRH antagonist in IVF ovarian hyperstimulation? Fertil Steril 2002;76(Suppl 3):S22.
  2. Chung K, Krey L, Ambrosini G, Katz J, Noyes N. Follicular serum androgen profiles differ when GnRH agonists and antagonists are used. Fertil Steril 2002;76(Suppl 3):S173-4.
  3. Chung K, Barnhart K, Sammel MD, Zhou L, Guo W, Hummel A. Decline of serum beta-hCG and spontaneous abortion: defining the normal curve. Fertil Steril 2003;80(Suppl 3):S87-8.
  4. Chung K, Schafer D, Knee G, Efymow B, Blasco L, Patrizio P. Sperm cryopreservation for male patients with cancer: an epidemiological analysis. Fertil Steril 2003;80(Suppl 3):S115.
  5. Chung K, Coutifaris C, Chalian R, Lin K, Castlebaum A, Barnhart KT. Factors influencing adverse perinatal outcomes in pregnancies achieved through use of assisted reproductive technology (ART). Fertil Steril 2005;84(Suppl 1):S108-9.
  6. Chung K, Sammel MD, Zhou L, Hummel A, Guo W, Barnhart KT. Defining the decline in human chorionic gonadotropin (hCG) for complete resolution of chemical pregnancies. Fertil Steril 2005;84(Suppl 1):S156.
  7. Chung K, Sammel MD, Coutifaris C, Chalian R, Freedman MF, Barnhart KT. Viable pregnancies resulting from in vitro fertilization (IVF): How fast does the serum human chorionic gonadotropin (hCG) rise? Fertil Steril 2005;84(Suppl 1):S236.
  8. Barnhart K, Chung K, Lorch S, Frederick M, Huang X, Zhang J. Surgical management of first trimester pregnancy failure is more effective and potentially less costly than medical management: A cost effectiveness analysis. J Soc Gynecol Investig 2006;13(Suppl):269-70.
  9. Jain JK, Francis MM, Marsh EM, McConnell G, Quinn P, Chung K, Paulson RJ. Oocyte cryopreservation: A promising strategy for circumventing the age-related decline in human fertility. Fertil Steril 2006;85(Suppl 2):S7.
  10. Marsh EM, Francis MM, McConnell G, Quinn P, Chung K, Paulson RJ, Jain JK. Oocyte cryopreservation: A comparison of GnRH agonist versus antagonist protocols. Fertil Steril 2006;85(Suppl 2):S9.
  11. Allen RB, Stanczyk FZ, Chung K, Pandian R, Paulson RJ. The clinical utility of the measurement of hyperglycosylated human chorionic gonadotropin during early pregnancy following assisted reproductive technology. Fertil Steril 2006;86(Suppl 2):S470.
  12. Allen RB, Fogle RH, Kalan MJ, Chung K, Paulson RJ. Permanent sutures do not improve tubal patency following cuff neosalpingostomy. Fertil Steril 2007;87(Suppl 2):S9.
  13. Paulson RJ, Chung K, Francis MM, Quinn P, Allen R, Jain JK. Establishment of a successful oocyte cryopreservation program at the University of Southern California. Presented at the 74th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, October 10-14, 2007, Henderson, Nevada.
  14. Allen RB, Francis MM, Chung K, Fogle RH, Kalan MJ, Paulson RJ. Oocyte cryopreservation (OC): Comparison of outcomes using autologous vs. donor oocytes. Fertil Steril 2007;88(Suppl 1):S352.
  15. Chung K, Fogle R, Allen R, Kalan M, Christenson K, Paulson R. Is microdose GnRH agonist in the absence of exogenous gonadotropins sufficient to achieve multiple ovarian follicle development? Fertil Steril 2008;89(Suppl 2):S8.
  16. Landay M, Epstein A, Bendikson K, Chung K, Paulson R. Current outcomes of zygote intrafallopian transfer (ZIFT) compared with conventional embryo transfer in women of advanced maternal age: Is there a benefit? Fertil Steril 2008;89(Suppl 2):S23.
  17. Landay MF, Fogle R, Marsh E, Kroener L, Ingles S, Paulson R, Chung K. Perinatal outcomes in pregnancies achieved through gestational surrogacy: Investigating the influence of treatment versus host effects on ART outcomes. Fertil Steril 2009;91(Suppl 1):S17.
  18. Rudick B, Friedman L, Chung K, Paulson R, Bendikson K. The progression of endometrial polyps in an infertile population. Fertil Steril 2009;91(Suppl 1):S23.
  19. Landay MF, Wilson M, Kim L, Stanczyk FZ, Paulson R, Chung K. Altered estrogen metabolism in breast cancer patients undergoing controlled ovarian hyperstimulation. Fertil Steril 2009;92(Suppl 1):S180.
  20. Chung K, Hovanessian-Larsen L, Hawes D, Taylor D, Paulson R, Pike M. Controlled ovarian hyperstimulation increases cell proliferation in normal breast tissue: Implications for the magnitude of possible breast cancer risk from infertility treatment. Fertil Steril 2009;92(Suppl 1):S181.
  21. Rudick BJ, Paulson R, Bendikson K, Chung K. The status of oocyte cryopreservation in the United States. Fertil Steril 2009;92(Suppl 1):S187.
  22. Baker M, Chung K, Bendikson K, Stanczyk F, Patel S, Opper N, Paulson R. Serum anti-mullerian hormone (AMH) levels as a predictor of pregnancy in women over 40 years of age. Reprod Sci 2010;17(Suppl):252A.
  23. Rubal L, Sanchez M, Opper N, Bendikson K, Chung K, Paulson RJ. Nausea and vomiting in early pregnancy following controlled ovarian hyperstimulation (COH): Effect of estradiol (E2) and hCG levels. Reprod Sci 2010;17(Suppl):312A.
  24. Rubal L, Opper N, Bendikson K, Chung K, Paulson R. In vitro fertilization outcomes in superpoor responders: Effect of microdose human chorionic gonadotropin boost. Fertil Steril 2010;93(Suppl 1):S21.
  25. Werthman P, Boostanfar R, Chang W, Chung K, Danzer H, Koopersmith T, Ringler G, Shamonki M, Surrey M, Vermesh M, Wilcox J. Use of testicular sperm/intracytoplasmic sperm injection yields high pregnancy rates in couples who failed multiple in vitro fertilization cycles owing to high levels of sperm DNA fragmentation. Fertil Steril 2010;93(Suppl 1):S21.
  26. Rubal LA, Sammel MD, Takacs P, Stanczyk F, Barnhart K, Chung K. Hyperglycosylated hCG in early pregnancy and its use as a diagnostic marker for ectopic pregnancy. Fertil Steril 2010;94(Suppl):S13.
  27. Rausch ME, Sammel M, Takacs P, Chung K, Shaunik A, Barnhart K. Multiple marker test for the accurate diagnosis of ectopic pregnancy. Fertil Steril 2010;94(Suppl):S34.
  28. Rudick B, Ingles SA, Stanczyk F, Chung K, Paulson R, Bendikson K. Characterizing the role of vitamin D levels on IVF outcomes: Stimulation, embryo, or endometrium? Fertil Steril 2010;94(Suppl):S72.
  29. Baker MB, Chung K, Bendikson KA, Harris M, Opper N, Paulson RJ. A pilot study to evaluate polyunsaturated fatty acid profiles in IVF patients: Effect on embryo morphology and pregnancy. Fertil Steril 2010;94(Suppl):S91.
  30. Sammel MD, Cary MS, Guo W, Takacs P, Chung K, Barnhart KT. hCG rise in early pregnancy differs by race. Fertil Steril 2010;94(Suppl):S181.
  31. Barnhart KT, Sammel MD, Chung K, Takacs P, Shaunik A, O’Flynn K, O’Brien K. Validation of prediction of location of a symptomatic early gestation based solely on clinical presentation. Fertil Steril 2010;94(Suppl):S186.
  32. Rubal L, Allen R, Stanczyk F, Patel S, Bendikson K, Paulson R, Chung K. The aromatase inhibitor anastrozole: A novel treatment for complex atypical endometrial hyperplasia in premenopausal women who desire fertility preservation. Reprod Sci 2011; 18(Suppl):258A.
  33. Rudick B, Ingles SA, Stanczyk F, Chung K, Paulson R, Bendikson K. The role of vitamin D levels on IVF outcomes in donor-recipient cycles. Fertil Steril 2011;95(Suppl):S8.
  34. Barnhart KT, Morse CB, Allen-Taylor L, Takacs P, Chung K, Sammel MD. When serial human chorionic gonadotropin (HCG) is misleading: Staying ahead of the curve. Fertil Steril 2011;96(Suppl):S89.
  35. Rubal L, Opper N, Kashani B, Paulson RJ, Chung K. Tubal transfer prior to day 3 is associated with improved perinatal outcomes after IVF. Fertil Steril 2011;96(Suppl):S274.
  36. Shaunik A, Sammel MD, Cary MS, Chung K, Takacs P, Barnhart KT. Risk factors influencing hCG decline in a spontaneous miscarriage. Fertil Steril 2011;96(Suppl):S282.
  37. Mucowski SJ, Muderspach L, Paulson RJ, Templeman C, Chung K. Successful pregnancy resulting from IVF after severe recurrent cervical stenosis secondary to radical trachelectomy. Fertil Steril 2012;97(Suppl):S19.
  38. Baker M, Cross M, Waisman J, Bendikson K, Paulson R, Chung K. A novel ovarian stimulation protocol utilizing a combination of tamoxifen and aromatase inhibition for fertility preservation in breast cancer patients. Fertil Steril 2012;98(Suppl):S8-9.
  39. Quaas AM, Melamed A, Chung K, Bendikson KA, Paulson RJ. Egg banking in the USA: Current status of commercially available cryopreserved oocytes. Fertil Steril 2012;98(Suppl):S65.
  40. Dillon KE, Sioulas VD, Chung K, Sammel M, Takacs P, Barnhart KT. Ectopic pregnancies in disguise: Human chorionic gonadotropin (HCG) curves in women with an ectopic pregnancy mimic other outcomes and differ by race and ethnicity. Fertil Steril 2012;98(Suppl):S86.
  41. Dillon KE, Sammel M, Senapatik S, Takacs P, Chung K, Barnhart KT. Falling human chorionic gonadotropin (hCG) curves in pregnancies of unknown location: Defining the window of concern. Fertil Steril 2012;98(Suppl):S199-200.
  42. Senapati S, Takacs P, Chung K, Shaunik A, Barnhart KT, Sammel M. Placental-like growth factor (PIGF) as a marker of ectopic pregnancy: Validation in a case control study. Fertil Steril 2012;98(Suppl):S200.
  43. Quaas AM, Chung K, Bendikson KA, Paulson RJ. Legal implications of commercial “Egg Banking”: Variations in state laws concerning the use of cryopreserved donor oocytes in the USA. Fertil Steril 2013;99(Suppl):S5.
  44. Burks H, Opper N, Khetan V, Schapiro L, Paulson R, Bendikson K, Chung K. The relationship between body mass index and quantitative serum HCG levels following HCG trigger in in vitro fertilization cycles. Fertil Steril 2013;99(Suppl):S5.
  45. Bendikson KA, Chung K, Jabara S, Quaas A, Mucowski S, Paulson RJ. Low-dose HCG can complete follicle maturity: The unstimulated IVF model. Fertil Steril 2013;99(Suppl):S28.
  46. Gualtieri M, Lee F, Stanczyk F, Patel S, Bendikson K, Paulson R, Chung K. Does the use of tamoxifen during controlled ovarian hyperstimulation alter estrogen metabolism favoring a protective effect on breast cancer risk. Fertil Steril 2013;99(Suppl):S30-1.
  47. Haunschild C, Sammel M, Chung K, DeMichele A, Su HI. Pre-chemotherapy levels of follicle stimulating hormone and anti-Mullerian hormone predict time to return of ovarian function in young breast cancer patients. Fertil Steril 2013;100(Suppl):S44.
  48. Dominick SA, Whitcomb BW, Gorman JR, Chung K, Mersereau JM, Su HI. Female young adult cancer survivors who undergo fertility preservation delay pregnancy attempts. Fertil Steril 2013;100(Suppl):S117.
  49. Chung K, Sammel M, Stanczyk F, Patel S, Su I. Can AMH be used as a marker of ovarian reserve in young breast cancer patients taking tamoxifen? Fertil Steril 2013;100(Suppl):S163.
  50. Chung K, Stanczyk F, Ma L, Sammel M, Haunschild C, Su I. Can ultrasensitive AMH assays detect ovarian function in older reproductive-aged women with breast cancer? Fertil Steril 2013;100(Suppl):S164.
  51. Burks HR, Stanczyk F, Wilson M, Paulson R, Bendikson K, Chung K. Can adverse obstetric outcomes after frozen embryo transfer be predicted by estradiol levels or endometrial thickness prior to transfer? Fertil Steril 2013;100(Suppl):S282.
  52. Gualtieri M, Miki T, Ross L, Chung K, Francis M, Paulson L, Paulson RJ. Successful induction of induced pluripotent stem cells (iPSC’s) from human granulosa cells (hGC’s). Fertil Steril 2014;101(Suppl):e5.
  53. Burks H, Ross L, Opper N, Stanczyk F, Chung K. Can ultrasensitive anti-müllerian hormone testing predict failed response to ovarian stimulation? Fertil Steril 2014;101(Suppl):e16-7.
  54. Ross L, Ingles S, Rudick B, Stanczyk F, Ma L, Chung K, Bendikson K. Correlation of serum anti-mullerian hormone with vitamin D levels in women undergoing IVF and egg donation. Fertil Steril 2014;101(Suppl):e24-5.
  55. Mucowski SJ, Bendikson K, Paulson R, Chung K. Current utilization status of cryopreserved oocytes in the United States. Fertil Steril 2014;101(Suppl):e31-2.
  56. Gualtieri M, Miki T, Chung K, Bendikson K, Francis M, Paulson RJ. Successful telomere lengthening in induced pluripotent stem cells (iPSCs) derived from human granulosa cells (hGCs) of women with diminished ovarian reserve (DOR). Fertil Steril 2014;102(Suppl):e103.
  57. Jones T, Gualtieri M, Bruno-Gaston J, Chung K, Paulson R, Bendikson K. Evaluation of clomiphene citrate stair-step protocol for ovulation induction. Fertil Steril 2014;102(Suppl):e138.
  58. Burks HR, Buckbinder J, Bendikson KA, Chung K, Jabara S, Paulson RJ. Success of developmentally delayed cleavage stage embryos in frozen embryo transfer. Presented at the 81st Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, October 22-26, 2014, Marana, Arizona.
  59. Ross L, Jones T, Ingles S, Rudick B, Pandian R, Stanczyk F, Chung K, Paulson RJ, Bendikson, K. Characterization of bioavailable vitamin D status in non-Hispanic white and Asian populations. Presented at the 81st Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, October 22-26, 2014, Marana, AZ.
  60. Ross L, Jones T, Ingles S, Rudick B, Pandian R, Stanczyk F, Chung K, Paulson RJ, Bendikson KB. Redefining the diagnosis of vitamin D deficiency in IVF patients. Presented at the annual meeting of The Endocrine Society, March 5-8, 2015, San Diego, CA.
  61. Burks H, Buckbinder J, Bendikson K, Chung K, Jabara S, Paulson RJ. Developmentally delayed cleavage-stage embryos maintain high implantation rates in frozen embryo transfers. Fertil Steril 2015;103(Suppl):e15.
  62. Burks H, Bruno-Gaston J, Stanczyk F, Bendikson K, Paulson R, Chung K. Is endometrial preparation during frozen embryo transfer associated with adverse obstetrical outcomes? Fertil Steril 2015;103(Suppl):e16.
  63. Ross L, Stanczyk F, Sudhinaraset A, Paulson R, Chung K. Evaluating the impact of anti-estrogenic medications on gonadotropin levels and oocyte yield during controlled ovarian hyperstimulation (COH) in breast cancer patients. Fertil Steril 2015; 103(Suppl):e32.
  64. Woo I, Stanczyk F, Patel S, Su HI, Chung K. Are there longitudinal changes in serum estradiol due to tamoxifen in premenopausal women with breast cancer: A prospective cohort study. Fertil Steril 2015;103(Suppl):e41.
  65. Louie K, Ross L, Jones T, Rudick B, Chung K, Bendikson K. Why are IVF pregnancy rates lower in women of Asian ethnicity: An analysis of ethnicity-matched oocyte donor cycles. Fertil Steril 2015;104(Suppl):e143.
  66. Hindoyan RH, Woo I, Ingles S, Paulson R, Chung K. Perinatal outcomes in pregnancies achieved through gestational surrogacy: Investigating the influence of treatment versus host effects on assisted reproductive technology outcomes. Fertil Steril 2015;104(Suppl):e221.
  67. Ross L, Clarke NJ, Stanczyk FZ, Chung K. Tamoxifen metabolites in breast cancer patients undergoing controlled ovarian hyperstimulation (COH): Are we achieving therapeutic levels. Fertil Steril 2015;104(Suppl):e261.
  68. Jordan A, Ribustello L, Jordan A, Danzer H, DiMattina M, Nakhuda G, Zhang J, Dudley P, Chung K, Munne S. Pregnancy outcomes per transfer after PGS via array CGH is consistent through maternal age. Fertil Steril 2015;104(Suppl):e339.
  69. Marks C, Rodriguez S, Kumar N, Field W, Chung K, Bendikson K. Pan-ethnic carrier screening for cystic fibrosis: A call for a standardized expanded mutation panel. Presented at the 34th Annual Meeting of the National Society of Genetic Counselors, October 21-23, 2015, Pittsburgh, PA.
  70. Woo I, Ingles S, Sriprasert I, Paulson R, Stanczyk F, Chung K. The role of angiogenic markers in adverse perinatal outcomes: Fresh vs. frozen embryo transfers. Fertil Steril 2016;105(Suppl):e7.
  71. Ho J, Woo I, Bendikson K, Paulson R, Chung K. Oocyte cryopreservation is as effective as embryo cryopreservation in achieving live births. Fertil Steril 2016;105(Suppl):e21-2.
  72. Salem W, Bendikson K, Paulson R, Chung K. Oocyte cryopreservation for cancer patients is inconsistently and suboptimally covered among national health insurance companies. Fertil Steril 2016;105(Suppl):e36.
  73. Woo I, Hindoyan R, Pandian R, Stanczyk F, Bendikson K, Chung K. Do levels of soluble LH receptors predict effectiveness of exogenous gonadotropins in controlled ovarian hyperstimulaton? Fertil Steril 2016;105(Suppl):e42.
  74. Woo I, Davenport E, Ingles SA, Stanczyk FZ, Chung K, Bendikson K, Paulson R. The concentration of commercial HCG trigger is imprecise and inaccurate. Fertil Steril 2016;106(Suppl):e56.
  75. Salem W, Ho JR, Bendikson KA, Chung K, Paulson R. IVF patients over age 39 experience decreased cost effectiveness and live birth rates with preimplantation genetic screening: A decision analytic model and cost effectiveness analysis. Fertil Steril 2016;106(Suppl):e60.
  76. Salem W, Ho J, Bendikson KA, Chung K, Paulson R. Modified natural cycle IVF increases value and access to care over traditional IVF for good prognosis patients: A decision analytic model and cost effectiveness analysis. Fertil Steril 2016; 106(Suppl):e74.
  77. Ho JR, Arrach N, Salem W, Ingles S, Bendikson K, Chung K, Paulson R, Ahmady A. Elevated mitochondrial DNA in embryos reflects aneuploidy and correlates with developmental arrest. Fertil Steril 2016;106(Suppl):e144.
  78. Ho JR, Arrach N, Salem W, Ingles SA, Bendikson K, Chung K, Paulson R, Ahmady A. Discordance rates between day 3 and day 6 chromosome results and the predictive value of time-lapse morphokinetics. Fertil Steril 2016;106(Suppl):e157.

INVITED PRESENTATIONS:

  1. Sperm cryopreservation in male patients with cancer: An epidemiological analysis. Presented at Grand Rounds, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania, October, 2004.
  2. Recurrent pregnancy loss. Presented at the RESOLVE’s 14th Annual Fall Symposium titled “Infertility & Family Building Options,” Irvine, California, October, 2005.
  3. Navigating fertility treatment. Presented at the RESOLVE’s 15th Annual Fall Symposium titled “Infertility & Family Building Options,” Irvine, California, October 28, 2006.
  4. Polycystic ovary syndrome in the adolescent. Presented at Grand Rounds, Department of Pediatrics, Women’s and Children’s Hospital, Keck School of Medicine of the University of Southern California, Los Angeles, California, August 29, 2006.
  5. Reproductive health in your 20’s, 30’s, 40’s and beyond. Presented at the Step Up Women’s Network’s Women’s Health Panel: Fertility and Pathways to Parenthood. Beverly Hills, California, January 30, 2007.
  6. Aging and reproduction. Presented at the Verdugo Hills Medical Center, Glendale, California, February 15, 2007.
  7. Options for fertility in female patients with cancer. Presented at Hematology Grand Rounds, Keck School of Medicine of the University of Southern California, Los Angeles, California, April 13, 2007.
  8. Options for fertility in female chemotherapy patients: The current status. Presented at the Weekly Tumor Board, Desert Regional Medical Center, Palm Springs, California, May 10, 2007.
  9. Assisted reproductive technology: Decision-making and perinatal implications. Presented at the annual meeting of the Perinatal Advisory Council: Leadership, Advocacy and Consultation, Burbank, California, June 7, 2007.
  10. Options for fertility preservation in female patients with cancer: The current status. Presented at Grand Rounds, USC/Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, California, June 26, 2007.
  11. Options for fertility preservation in female patients with cancer. Presented at Grand Rounds, Department of Obstetrics and Gynecology, Women’s and Children’s Hospital, Keck School of Medicine of the University of Southern California, Los Angeles, California, August 24, 2007.
  12. Aging & reproduction. Presented at the RESOLVE’s 16th Annual Fertility & Adoption Symposium titled “Family Building Options,” Los Angeles, California, January 8, 2008.
  13. Advances in oocyte preservation technology. Presented at Grand Rounds, Saint John’s Health Center, Santa Monica, California, June 24, 2008.
  14. Ovarian stimulation protocols and understanding options for low responders. Presented at the RESOLVE’s Family Building Symposium, Long Beach, California, October 18, 2008.
  15. Rise to action 2009. Presented at the Event for Children’s Cause for Cancer Advocacy, Keck School of Medicine of the University of Southern California, Los Angeles, California, February 7, 2009.
  16. Fertility preservation. Presented at the Arizona ACOG Section and Phoenix Ob/Gyn Society Midwinter Symposium, Phoenix, Arizona, February 21, 2009.
  17. Assisted reproductive technologies. Presented at the Ventura County Medical Center, Ventura, California, March 18, 2009.
  18. Fertility preservation. Presented at the Breast Cancer Care & Research Fund sponsored Wellness Lecture Series 2009, El Segundo, California, October 3, 2009.
  19. Fertility treatments, concerns/risks, and legal issues related to fertility. Presented at the University of Southern California Gould School of Law, Los Angeles, California, October 5, 2009.
  20. Cancer and fertility: Understanding options for patients and survivors of childhood cancer. Presented at the Twenty-Fourth Regional Conference on Pediatric Hematology and Oncology Nursing, Indian Wells, California, May 13, 2010.
  21. Polycystic ovarian syndrome. Presented at the Northridge Hospital, Roscoe Campus, Northridge, California, June 11, 2010.
  22. Fertility and pregnancy in young women affected by breast cancer. Presented at the 11th Annual Conference for Young Women Affected by Breast Cancer, Orlando, Florida, February 25-27, 2011.
  23. Cancer and fertility: Options for young adults with cancer. Presented at the Eleventh Annual Psychosocial Seminar: The Unique Needs of the Young Adult Facing Cancer, USC Norris Cancer Hospital, Keck School of Medicine of the University of Southern California, Los Angeles, California, March 18, 2011.
  24. Oncofertility. Presented at Grand Rounds, Department of Surgery, Kaiser Permanente, Los Angeles, California, May 31, 2011.
  25. Oncofertility. Presented at Grand Rounds, Department of Obstetrics and Gynecology, Kaiser Permanente, Los Angeles, California, August 18, 2011.
  26. Options for fertility preservation in women diagnosed with cancer. Presented to the Hematology Oncology Division, University of California, Irvine, Orange, California, June 21, 2012.
  27. Options for fertility preservation in women diagnosed with cancer. Presented to the Young Survivors Support Group, University of California, Irvine, Orange, California, July 17, 2012.
  28. Options for fertility preservation after diagnosis of breast or ovarian malignancies. Presented at the Hematology Oncology Grand Rounds, Olive View Medical Center, Sylmar, California, September 12, 2012.
  29. Why ask why: Should the reason for oocyte cryopreservation matter? ASRM Interactive Session, Fertility Preservation Special Interest Group Interactive Session. 68th annual meeting of the American Society for Reproductive Medicine, San Diego, California, October 23, 2012.
  30. Cancer and fertility: Understanding options for patients and survivors of childhood cancer. Presented at Children’s Hospital of Los Angeles, Los Angeles, California, January 10, 2013.
  31. Fertility and reproductive options. Presented at the Saddleback Memorial Medical Center, Laguna Hills, California, July 18, 2013.
  32. Options for fertility preservation in female patients with cancer: The current status. Presented at Grand Rounds, USC/Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, California, October 25, 2013.
  33. Fertility in-service. Options for fertility preservation in female patients with cancer. Presented at the USC/Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, California, November 8, 2013.
  34. Cancer and fertility: Understanding options for patients and survivors of childhood cancer. Presented at Pediatrics Grand Rounds, City of Hope, Duarte, California, May 30, 2014.
  35. Fertility in the oncology patient. Presented in the Department of Medical Oncology, USC/Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, California, January 16, 2015.
  36. Advances in fertility options for survivors of childhood cancer. Presented at the Late Effects Tumor Board of Children’s Hospital of Los Angeles, Los Angeles, California, January 22, 2015.
  37. Understanding options for fertility preservation and fertility assessment in the adolescent and young adult patient. Presented at the AYA (Adolescent and Young Adult) Cancer Symposium, USC/Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, California, March 21, 2015.
  38. Fertility in cancer patients. Presented at the USC/Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, California, April 14, 2015.
  39. Options for fertility preservation and fertility care in the female cancer patient. Presented at the Obstetrical and Gynecological Assembly of Southern California, Marina Del Rey, California, May 8, 2015.
  40. Options for fertility care in adolescents and young adults with cancer. Presented at Grand Rounds, Children’s Hospital of Los Angeles, Division of Hematology, Oncology and Blood & Marrow Transplantation, Los Angeles, California, September 23, 2015.
  41. Oncofertility. Presented in the Department of Obstetrics and Gynecology, Kaiser Permanente Sunset, Los Angeles, California, July 28, 2016.
  42. Fertility in cancer patients. Presented to Hematology/Oncology Fellows, LAC+USC Medical Center, Los Angeles, California, October 28, 2016.
  43. Infertility in cancer patients. To be presented at Grand Rounds, White Memorial Medical Center, Los Angeles, California, January 11, 2017.